Effect of Primary Dysmenorrhea on Muscle Activity in Young Adult Females
NCT ID: NCT07095725
Last Updated: 2025-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
72 participants
OBSERVATIONAL
2025-07-01
2025-11-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Core Stability vs. Traditional Physical Therapy: A Comparative Study on Alleviating Low Back Pain in Dysmenorrhea
NCT06807229
Effect of Lumbar Proprioception Training on Primary Dysmenorrhea
NCT06051435
Abdominal Muscle Strengthening for Menstrual Symptoms in Primary Dysmenorrhea
NCT07130292
Effect of Kinesio Taping Versus Myofascial Release on Menstrual Low Back Pain
NCT06280989
Effect of Integrated Neuromuscular Inhibition Technique in Females With Menstrual Low Back Pain
NCT05461846
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
PD is commonly associated with visceral pain and various musculoskeletal symptoms, including abdominal and back pain (Yacubovich et al., 2019). This can reduce the maximum voluntary contraction of the affected muscles, compromising their ability to provide adequate support and stability (Merkle et al., 2020). Persistent pain can disrupt postural stability and balance, raising the risk of injury by compromising stability and muscle function.
Research highlights the impact of primary dysmenorrhea (PD) on muscle function, particularly in the abdominal and back muscles, contributing to pain and reduced stability. Oladosu et al. (2018) found that abdominal muscle activity precedes menstrual pain, suggesting a neuromuscular link. Similarly, Karakus et al. (2022) and Álvarez et al. (2024) reported altered activation and reduced endurance in stabilizing muscles, including the transversus abdominis, obliques, and lumbar multifidus, with muscle thinning that may impair spinal stability. These studies emphasize PD's effect on muscle function, but further research is needed to explore variations across severities and guide effective treatments.
When these weakened muscles because of dysmenorrhea are subjected to increased or sudden activity during daily living tasks, such as lifting, bending, or other physical exertions, the risk of injury to the structures they are designed to protect is significantly heightened (Escamilla et al., 2010; Polat et al., 2022).
However, to the best of the authors' knowledge, no research has yet explored the relationship of abdominal and back muscle activity patterns to PD and their variations across different severities of dysmenorrhea, which directly contributes to females' quality of life.
Understanding this association could have significant clinical implications and contribute to new knowledge that helps physical therapists determine the need for custom-designed prevention and treatment programs for females with PD. By raising awareness of the potential musculoskeletal risks associated with PD, this study emphasizes the importance of minimizing strenuous activities during menstruation to reduce muscle strain or injury, ultimately enhancing overall health and well-being during this period.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A: Mild dysmenorrhea
Females with mild PD, scoring (1-4) on the WaLLID scale.
Record EMG maximum amplitude from rectus abdominis, erector spinae L3 level
EMG Electrode Placement and Muscle Assessment:
Electrodes for the rectus abdominis were placed longitudinally at the umbilical level. For the erector spinae, L3 was located using a line between the posterior superior iliac crests, and electrodes were placed \~3 cm lateral to the L3 spinous process.
Assessment:
Rectus Abdominis: In the crook-lying position, participants performed a slow curl-up (\~35-40°), holding for 10 seconds.
Erector Spinae: In the prone position with a 10-cm pad under the abdomen, participants lifted the upper body with neutral cervical alignment for 10 seconds.
Each test was repeated three times with 2-minute rest intervals.
Group B: Moderate dysmenorrhea
Females with moderate PD, scoring (5-7) on the WaLLID scale.
Record EMG maximum amplitude from rectus abdominis, erector spinae L3 level
EMG Electrode Placement and Muscle Assessment:
Electrodes for the rectus abdominis were placed longitudinally at the umbilical level. For the erector spinae, L3 was located using a line between the posterior superior iliac crests, and electrodes were placed \~3 cm lateral to the L3 spinous process.
Assessment:
Rectus Abdominis: In the crook-lying position, participants performed a slow curl-up (\~35-40°), holding for 10 seconds.
Erector Spinae: In the prone position with a 10-cm pad under the abdomen, participants lifted the upper body with neutral cervical alignment for 10 seconds.
Each test was repeated three times with 2-minute rest intervals.
Group C: Severe dysmenorhhea
Females with severe PD, scoring (8-12) on the WaLLID scale.
Record EMG maximum amplitude from rectus abdominis, erector spinae L3 level
EMG Electrode Placement and Muscle Assessment:
Electrodes for the rectus abdominis were placed longitudinally at the umbilical level. For the erector spinae, L3 was located using a line between the posterior superior iliac crests, and electrodes were placed \~3 cm lateral to the L3 spinous process.
Assessment:
Rectus Abdominis: In the crook-lying position, participants performed a slow curl-up (\~35-40°), holding for 10 seconds.
Erector Spinae: In the prone position with a 10-cm pad under the abdomen, participants lifted the upper body with neutral cervical alignment for 10 seconds.
Each test was repeated three times with 2-minute rest intervals.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Record EMG maximum amplitude from rectus abdominis, erector spinae L3 level
EMG Electrode Placement and Muscle Assessment:
Electrodes for the rectus abdominis were placed longitudinally at the umbilical level. For the erector spinae, L3 was located using a line between the posterior superior iliac crests, and electrodes were placed \~3 cm lateral to the L3 spinous process.
Assessment:
Rectus Abdominis: In the crook-lying position, participants performed a slow curl-up (\~35-40°), holding for 10 seconds.
Erector Spinae: In the prone position with a 10-cm pad under the abdomen, participants lifted the upper body with neutral cervical alignment for 10 seconds.
Each test was repeated three times with 2-minute rest intervals.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ranges from 18 to 25 years.
* BMI ranges from 20 to 25 kg/m2 .
* Onset of menstrual pain 6-24 months after menarche.
* Having a regular menstrual cycle (28 ± 7 days with no intermittent bleeding).
* Their PD symptoms will be determined according to the WaLLID questionnaire and will be classified into mild PD (1-4), moderate PD (5-7), severe PD (8-12).
* All participants are virgins.
Exclusion Criteria
* Use of antidepressant or steroid drugs.
* Secondary dysmenorrhea.
* Musculoskeletal problems in the abdominal region, pelvic region, or spine.
* Surgical history involving the abdominal region, pelvic region, or spine in the last year.
* Any psychiatric or gynecological problems.
18 Years
25 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mahenour Esmail Taha
Teaching Assistant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mahenour Esmail Shendy, Bachelor of Physical Therapy
Role: PRINCIPAL_INVESTIGATOR
Teaching Assistant of Physical Therapy For Women's Health- Misr University for Science and Technology
Doaa Ahmed Osman, Assistant Professor
Role: STUDY_CHAIR
Physical Therapy for Women's Health - Faculty of Physical Therapy- Cairo University
Manal Ahmed Elshafei, Lecturer
Role: STUDY_DIRECTOR
Physical Therapy for Women's Health - Faculty of Physical Therapy- Cairo University
Ihab Kamal Younis, lecturer
Role: STUDY_DIRECTOR
Obstetrics and Gynecology department - Faculty of Medicine Misr university for science and technology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Misr University for Science and Technology
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P.T.REC\012\005884
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.